Physiomics Plc (AIM:PYC)

Market Cap	2.27M +89.2%
Revenue (ttm)	1.01M +85.8%
Net Income	-485.25K
EPS	-0.00
Shares Out	453.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,270,262
Average Volume	5,676,040
Open	0.5000
Previous Close	0.5000
Day's Range	0.4510 - 0.5160
52-Week Range	0.2525 - 0.7990
Beta	0.95
RSI	54.22
Earnings Date	May 15, 2026

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxf...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 10
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: PYC

Financial Performance

In fiscal year 2025, Physiomics's revenue was 834,156, an increase of 46.20% compared to the previous year's 570,561. Losses were -415,254, -31.85% less than in 2024.